Influenza: MOnitoring Vaccine effectiveness in Europe
The I-MOVE network aims to measure influenza vaccine effectiveness in Europe, in a way that is scientifically and financially independent from vaccine manufacturers. It publishes results immediately after the start of a seasonal epidemic or pandemic.
- Full title: Influenza: MOnitoring Vaccine effectiveness in Europe
- Deliverables: see publications on the right
- Funding: European Commission
- Project partners: 26 partners from 26 European countries
- Nivel involvement: project partner
- Nivel experts: Joke Korevaar PhD, Mariëtte Hooiveld PhD
- International project website: I-MOVE+.eu
What can Nivel do for you?
For more information about Nivel as a partner in healthcare services research, please feel free to contact our manager International Projects Inge van Houdt PhD. We are looking forward tot get in touch with you.